Dianthus Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Dianthus Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Dianthus Therapeutics Inc
Rating: 2.11933325
Author: Trendlyne DVM scores

about

Dianthus Therapeutics Inc. is a clinical-stage biotechnology company dedicated to developing potentially best-in-class therapies for patients with severe autoimmune diseases. The company operates as a single segment and has one reportable segment, fo...

80.58 1.68 (2.13%)

New 52W High in past week

337.8K

XNAS Volume

XNAS 18 Mar, 2026 1:56 PM (EDT)

Not Eligible

Expensive Valuation

4.8 / 100

Technically Bullish

79.9 / 100

127

1Yr Price target upside is 58%

11 analysts

Dianthus Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Dianthus Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Dianthus Therapeutics Inc. is a clinical-stage biotechnology company dedicated to developing potentially best-in-class therapies for patients with severe autoimmune diseases. The company operates as a single segment and has one reportable segment, fo...

New 52W High in past week

SWOT Analysis

Dianthus Therapeutics Inc Live Price Chart